Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / Diabetes / May 2007

Tip: Looking for answers? Try searching our database.

Glaxo's Avandia Study in Jeopardy

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
Kurt - 30 May 2007 07:17 GMT
http://diabetes.org/diabetesnewsarticle.jsp?storyId=15158739&filename=20070528/r
euters20070528health00000010reutershealthewEDIT.xml


or

http://tinyurl.com/2ygd7r

Glaxo's Avandia Study in Jeopardy: Official

(excerpt)

NEW YORK (Reuters) - Drug maker GlaxoSmithKline's medical director
said the company's study of the heart risk associated with its Avandia
diabetes treatment may be in jeopardy because patients have dropped
out following reports of the drug's risks, The New York Times reported
on Saturday.

Dr. Ronald Krall told the newspaper he did not know how many of the
4,450 patients in the drug trial had withdrawn but said Glaxo diabetes
was worried it may not be able to complete the trial, which is
scheduled to run through 2008.

Independent research committees overseeing the study, which is
designed to gauge any increased risk of heart attack or stroke for
people taking it, "are concerned about the ability of the study to
continue" and are "considering what to do to prevent people from
dropping out of the trial," the Times quoted Krall as saying.

The drug, Glaxo's No. 2 seller, has been used by some 6 million people
in the United States alone.
johnniemccoy@ - 30 May 2007 09:37 GMT
> http://diabetes.org/diabetesnewsarticle.jsp?storyId=15158739&filename=20070528/r
euters20070528health00000010reutershealthewEDIT.xml

>
[quoted text clipped - 25 lines]
> The drug, Glaxo's No. 2 seller, has been used by some 6 million people
> in the United States alone.

I wonder how many, of those 6 million (those who had no previous history of
heart trouble) suffered heart problems after taking Avandia.

John
Kurt - 30 May 2007 18:26 GMT
On May 30, 1:37?am, "johnniemccoy@" <johnniemc...@NOSPAMhotmail.com>
wrote:

> >http://diabetes.org/diabetesnewsarticle.jsp?storyId=15158739&filename...
>
[quoted text clipped - 28 lines]
> I wonder how many, of those 6 million (those who had no previous history of
> heart trouble) suffered heart problems after taking Avandia.

Hopefully, it's not a matter of "time will tell."  If I had taken
Avandia for any length of time I would want to be checked out
thoroughly.

Kurt
Jonathan Grobe - 30 May 2007 15:19 GMT
> http://diabetes.org/diabetesnewsarticle.jsp?storyId=15158739&filename=20070528/r
euters20070528health00000010reutershealthewEDIT.xml

>
[quoted text clipped - 11 lines]
> out following reports of the drug's risks, The New York Times reported
> on Saturday.

I don't see why they don't report interim results; they have
a few years worth of data. (My suspicion is they are not because
the results are bad--that the data show a higer risk of heart
problems...).

Signature

Jonathan Grobe

Mâck©® - 30 May 2007 16:02 GMT
>> http://diabetes.org/diabetesnewsarticle.jsp?storyId=15158739&filename=20070528/r
euters20070528health00000010reutershealthewEDIT.xml

>>
[quoted text clipped - 16 lines]
>the results are bad--that the data show a higer risk of heart
>problems...).

isn't there an ethical question when those doing the research want to
try and find a way to keep people on the medication, when 1. those
people do not want the med because they don't trust it and 2. because
there is a question as to it's safety.  People have the right to
refuse anything they do not want.

Signature

Mâck©® Deltec CoZmore Pumper
Type 1 since 1975
http://www.alt-support-diabetes.org
http://www.diabetic-talk.org
http://www.insulin-pumpers.org
http://www.pandora.com  enter "Jason & Demarco"

"To announce that there must be no criticism of the
President, or that we are to stand by the President
right or wrong, is not only unpatriotic and servile,
but is morally treasonable to the American public."
...Theodore Roosevelt

        (o ô)  
--ooO-(_)-Ooo--------------------

"I don't know half of you
half as well as I should like;
and I like less than half of you
half as well as you deserve."
             ....Bilbo Baggins

DISCLAIMER If you find a posting or message from me
offensive, inappropriate, or disruptive, please ignore it.
If you don't know how to ignore a posting, complain to
me and I will be only too happy to demonstrate...
.

Shawn Hirn - 31 May 2007 04:03 GMT
> >> http://diabetes.org/diabetesnewsarticle.jsp?storyId=15158739&filename=20070
> >> 528/reuters20070528health00000010reutershealthewEDIT.xml
[quoted text clipped - 23 lines]
> there is a question as to it's safety.  People have the right to
> refuse anything they do not want.

Of course, and no one is denying that.
guys@consolidated.net - 31 May 2007 06:16 GMT
>>> http://diabetes.org/diabetesnewsarticle.jsp?storyId=15158739&filename=20070528/r
euters20070528health00000010reutershealthewEDIT.xml

>>>
[quoted text clipped - 22 lines]
>there is a question as to it's safety.  People have the right to
>refuse anything they do not want.

A criteria that is thousands of years old is--- we use caution when
taking the advice of anyone with a vested interest.  Is
accepted by our society that we do not allow anyone
to sell a dangerous product.  The definition of
dangerous is set by an agency with no
personal interest in the company selling
a product.

Since diabetes has  an enlarged base of
potential customers there is concern
over diabetic items.   We have the
right to ban any product that is likely to
do harm or at least examine the
benefit/harm ratio.

An alternative is for some people in the selling companies take
responsibility or a drug they market.   Then serve long jail terms
if they fail. There would be few few drugs.

Most individuals are unqualified and lack the resources to
evaluate most drugs.
Kurt - 30 May 2007 18:24 GMT
> >http://diabetes.org/diabetesnewsarticle.jsp?storyId=15158739&filename...
>
[quoted text clipped - 16 lines]
> the results are bad--that the data show a higer risk of heart
> problems...).

I thought the same thing, Jonathan.  Maybe they should be forced to
reveal the data they have collected so far.  If it were positive, then
I bet they would have announced them already.

Kurt
redronin@juno.com - 30 May 2007 20:04 GMT
> >http://diabetes.org/diabetesnewsarticle.jsp?storyId=15158739&filename...
>
[quoted text clipped - 16 lines]
> the results are bad--that the data show a higer risk of heart
> problems...).

I would guess that the data is somewhat ambiguous, but with a negative
trend. If it were unambiguously positive or negative, the company
would reveal it either to clear the drugs name or to ward off
lawsuits. Some key metrics may not have reached staistical
significance.

We do know that Avandia does cause fluid retention, therefore it
shouldnt' be given to people with congestive heart failure, and can
reduce bone density. My take at this point is that it probably does
increase cardio events by some %, but we don't know   the risk level
for different subpopulations.

All drugs will have some side-effects and the TZDs in particular are
very powerful drugs with many possible actions. They do help with a1c
and may preserve beta-cell function.  But possibly in the future,
Januvia etc, would become 2nd line therapy, replacing the TZDs.
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.